KURA ONCOLOGY, INC. Earnings Per Share (Basic)
KURA ONCOLOGY, INC. (KURA) reported Earnings Per Share (Basic) of -$0.77 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-12
- KURA ONCOLOGY, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.77.
- KURA ONCOLOGY, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.83.
- KURA ONCOLOGY, INC. earnings per share, basic for the quarter ending 2025-12-31 was -$0.92.
- KURA ONCOLOGY, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.85.
- KURA ONCOLOGY, INC. earnings per share, basic for fiscal 2025 was -$3.18.
- KURA ONCOLOGY, INC. earnings per share, basic for fiscal 2024 was -$2.02.
- KURA ONCOLOGY, INC. earnings per share, basic for fiscal 2023 was -$2.08.
- KURA ONCOLOGY, INC. earnings per share, basic for fiscal 2022 was -$2.03.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.77 10-Q · filed 2026-08-12 | -$1.60 10-Q · filed 2026-08-12 | -$2.52 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$3.36 derived: net income ÷ weighted average shares · filed 2026-08-12 |
| 2026-03-31 | -$0.83 10-Q · filed 2026-05-12 | -$1.75 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$2.59 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$3.35 derived: net income ÷ weighted average shares · filed 2026-08-12 |
| 2025-12-31 | -$0.92 derived: net income ÷ weighted average shares · filed 2026-04-10 | -$1.77 derived: net income ÷ weighted average shares · filed 2026-04-10 | -$2.52 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$3.18 10-K · filed 2026-03-05 |
| 2025-09-30 | -$0.85 10-Q · filed 2025-11-04 | -$1.60 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$2.26 10-Q · filed 2025-11-04 | -$2.48 derived: net income ÷ weighted average shares · filed 2026-08-12 |
| 2025-06-30 | -$0.75 10-Q · filed 2026-08-12 | -$1.41 10-Q · filed 2026-08-12 | -$1.63 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$2.26 derived: net income ÷ weighted average shares · filed 2026-08-12 |
| 2025-03-31 | -$0.66 10-Q · filed 2026-05-12 | -$0.88 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$1.50 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$2.09 derived: net income ÷ weighted average shares · filed 2026-08-12 |
| 2024-12-31 | -$0.22 derived: net income ÷ weighted average shares · filed 2026-04-10 | -$0.85 derived: net income ÷ weighted average shares · filed 2026-04-10 | -$1.43 derived: net income ÷ weighted average shares · filed 2026-04-10 | -$2.02 10-K · filed 2026-03-05 |
| 2024-09-30 | -$0.63 10-Q · filed 2025-11-04 | -$1.21 derived: net income ÷ weighted average shares · filed 2025-11-04 | -$1.80 10-Q · filed 2025-11-04 | -$2.36 derived: net income ÷ weighted average shares · filed 2026-04-10 |
| 2024-06-30 | -$0.59 10-Q · filed 2025-08-07 | -$1.18 10-Q · filed 2025-08-07 | -$1.73 derived: net income ÷ weighted average shares · filed 2026-04-10 | -$2.24 derived: net income ÷ weighted average shares · filed 2026-04-10 |
| 2024-03-31 | -$0.59 10-Q · filed 2025-05-01 | -$1.14 derived: net income ÷ weighted average shares · filed 2026-04-10 | -$1.65 derived: net income ÷ weighted average shares · filed 2026-04-10 | -$2.18 derived: net income ÷ weighted average shares · filed 2026-04-10 |
| 2023-12-31 | -$0.55 derived: net income ÷ weighted average shares · filed 2026-04-10 | -$1.05 derived: net income ÷ weighted average shares · filed 2026-04-10 | -$1.58 derived: net income ÷ weighted average shares · filed 2026-04-10 | -$2.08 10-K · filed 2026-03-05 |
| 2023-09-30 | -$0.50 10-Q · filed 2024-11-07 | -$1.03 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$1.53 10-Q · filed 2024-11-07 | -$2.02 derived: net income ÷ weighted average shares · filed 2025-02-28 |
| 2023-06-30 | -$0.53 10-Q · filed 2024-08-08 | -$1.03 10-Q · filed 2024-08-08 | -$1.52 derived: net income ÷ weighted average shares · filed 2025-02-28 | -$2.05 derived: net income ÷ weighted average shares · filed 2025-02-28 |
| 2023-03-31 | -$0.50 10-Q · filed 2024-05-02 | -$0.99 derived: net income ÷ weighted average shares · filed 2025-02-28 | -$1.52 derived: net income ÷ weighted average shares · filed 2025-02-28 | -$2.04 derived: net income ÷ weighted average shares · filed 2025-02-28 |
| 2022-12-31 | -$0.49 derived: net income ÷ weighted average shares · filed 2025-02-28 | -$1.02 derived: net income ÷ weighted average shares · filed 2025-02-28 | -$1.54 derived: net income ÷ weighted average shares · filed 2025-02-28 | -$2.03 10-K · filed 2025-02-28 |
| 2022-09-30 | -$0.53 10-Q · filed 2023-11-02 | -$1.05 derived: net income ÷ weighted average shares · filed 2023-11-02 | -$1.54 10-Q · filed 2023-11-02 | -$2.03 derived: net income ÷ weighted average shares · filed 2024-02-27 |
| 2022-06-30 | -$0.52 10-Q · filed 2023-08-09 | -$1.01 10-Q · filed 2023-08-09 | -$1.50 derived: net income ÷ weighted average shares · filed 2024-02-27 | -$2.00 derived: net income ÷ weighted average shares · filed 2024-02-27 |
| 2022-03-31 | -$0.49 10-Q · filed 2023-05-10 | -$0.98 derived: net income ÷ weighted average shares · filed 2024-02-27 | -$1.48 derived: net income ÷ weighted average shares · filed 2024-02-27 | -$1.99 derived: net income ÷ weighted average shares · filed 2024-02-27 |
| 2021-12-31 | -$0.49 derived: net income ÷ weighted average shares · filed 2024-02-27 | -$0.99 derived: net income ÷ weighted average shares · filed 2024-02-27 | -$1.50 derived: net income ÷ weighted average shares · filed 2024-02-27 | -$1.97 10-K · filed 2024-02-27 |
| 2021-09-30 | -$0.50 10-Q · filed 2022-11-03 | -$1.01 derived: net income ÷ weighted average shares · filed 2022-11-03 | -$1.47 10-Q · filed 2022-11-03 | |
| 2021-06-30 | -$0.51 10-Q · filed 2022-08-03 | -$0.97 10-Q · filed 2022-08-03 | ||
| 2020-12-31 | -$1.69 10-K · filed 2023-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |